3. Summary
Global Markets Direct’s, Occlusive Arterial Disease (OAD) - Pipeline Review, H2
2012, provides an overview of the indication’s therapeutic pipeline. This report
provides information on the therapeutic development for Occlusive Arterial
Disease (OAD), complete with latest updates, and special features on late-stage
and discontinued projects. It also reviews key players involved in the
therapeutic development for Occlusive Arterial Disease (OAD). Occlusive
Arterial Disease (OAD) - Pipeline Review, Half Year is built using data and
information sourced from Global Markets Direct’s proprietary databases,
Company/University websites, SEC filings, investor presentations and featured
press releases from company/university sites and industry-specific third party
sources, put together by Global Markets Direct’s team.
Note*: Certain sections in the report may be removed or altered based on the
availability and relevance of data for the indicated disease.
4. Scope
- A snapshot of the global therapeutic scenario for Occlusive Arterial Disease (OAD).
- A review of the Occlusive Arterial Disease (OAD) products under development by
companies and universities/research institutes based on information derived from
company and industry-specific sources.
- Coverage of products based on various stages of development ranging from
discovery till registration stages.
Reasons to buy
- Identify and understand important and diverse types of therapeutics under
development for Occlusive Arterial Disease (OAD).
- Identify emerging players with potentially strong product portfolio and design
effective counter-strategies to gain competitive advantage.
- Plan mergers and acquisitions effectively by identifying players of the most
promising pipeline.
5. Table of Contents :
List of Tables 7
List of Figures 8
Introduction 9
Global Markets Direct Report Coverage 9
Occlusive Arterial Disease (OAD) Overview 10
Therapeutics Development 11
An Overview of Pipeline Products for Occlusive Arterial Disease (OAD) 11
Occlusive Arterial Disease (OAD) Therapeutics under Development by
Companies 13
Occlusive Arterial Disease (OAD) Therapeutics under Investigation by
Universities/Institutes 17
Late Stage Products 19
Comparative Analysis 19
Mid Clinical Stage Products 20
Comparative Analysis 20
Early Clinical Stage Products 21
Comparative Analysis 21
Discovery and Pre-Clinical Stage Products 22
Comparative Analysis 22……………
6. Please follow link if you want More Related
Reports :
Pipeline Review, H2 2012
http://www.aarkstore.com/search/viewresults.asp?searc
h=Pipeline Review, H2 2012&PubId=&pagenum=1
